🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Rivaroxaban - Medicines in Ireland

66 authorised products containing Rivaroxaban, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 66 authorised medicines
MedicineActive substanceLicence holderStatus
Rivaroxaban 10 mg film-coated tablets
PA22865/010/001
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 15 mg film-coated tablets
PA22865/010/002
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban 20 mg film-coated tablets
PA22865/010/003
Rivaroxaban Renata Pharmaceuticals (Ireland) Limited Not marketed
Rivaroxaban Accord 10 mg film-coated tablets
EU/1/20/1488/012-023
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 15 mg film-coated tablets
EU/1/20/1488/024-038
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 15 mg film-coated tablets Rivaroxaban Accord 20 mg film-coated tablets
EU/1/20/1488/039
Rivaroxaban, Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 2.5 mg film-coated tablets
EU/1/20/1488/001-011
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Accord 20 mg film-coated tablets
EU/1/20/1488/040-053
Rivaroxaban Accord Healthcare S.L.U.
Rivaroxaban Ascend 10 mg film-coated tablets
PA23429/007/002
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 15 mg film-coated tablets
PA23429/007/003
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 15 mg film-coated tablets Rivaroxaban Ascend 20 mg film-coated tablets
PA23429/007/005
Rivaroxaban, Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 2.5 mg film-coated tablets
PA23429/007/001
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Ascend 20 mg film-coated tablets
PA23429/007/004
Rivaroxaban Ascend GmbH Not marketed
Rivaroxaban Azure 10 mg film-coated tablets
PA1963/019/002
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 15 mg film-coated tablets
PA1963/019/003
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 15 mg film-coated tablets Rivaroxaban Azure 20 mg film-coated tablets
PA1963/019/005
Rivaroxaban, Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 2.5 mg film-coated tablets
PA1963/019/001
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Azure 20 mg film-coated tablets
PA1963/019/004
Rivaroxaban Cipla Europe Not marketed
Rivaroxaban Bluefish 10 mg film-coated tablets
PA1436/044/001
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 15 mg film-coated tablets
PA1436/044/002
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 15 mg film-coated tablets Rivaroxaban Bluefish 20 mg film-coated tablets
PA1436/044/004
Rivaroxaban, Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Bluefish 20 mg film-coated tablets
PA1436/044/003
Rivaroxaban Bluefish Pharmaceuticals AB Not marketed
Rivaroxaban Clonmel 10 mg film-coated tablets
PA0126/035/002
Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 15 mg film-coated tablets
PA0126/035/003
Rivaroxaban Clonmel Healthcare Ltd Marketed
Rivaroxaban Clonmel 15 mg film-coated tablets Rivaroxaban Clonmel 20 mg film-coated tablets
PA0126/035/005
Rivaroxaban, Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 2.5 mg film-coated tablets
PA0126/035/001
Rivaroxaban Clonmel Healthcare Ltd Not marketed
Rivaroxaban Clonmel 20 mg film-coated tablets
PA0126/035/004
Rivaroxaban Clonmel Healthcare Ltd Marketed
Rivaroxaban Grindeks 10 mg film-coated tablets
PA22992/008/001
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Grindeks 15 mg film-coated tablets
PA22992/008/002
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Grindeks 20 mg film-coated tablets
PA22992/008/003
Rivaroxaban AS Grindeks Not marketed
Rivaroxaban Krka 10 mg film-coated tablets
PA1347/098/002
Rivaroxaban KRKA, d.d., Novo mesto Marketed
Rivaroxaban Krka 15 mg film-coated tablets
PA1347/098/003
Rivaroxaban KRKA, d.d., Novo mesto Marketed
Rivaroxaban Krka 2.5 mg film-coated tablets
PA1347/098/001
Rivaroxaban KRKA, d.d., Novo mesto Not marketed
Rivaroxaban Krka 20 mg film-coated tablets
PA1347/098/004
Rivaroxaban KRKA, d.d., Novo mesto Marketed
Rivaroxaban MSN 10 mg film-coated tablets
PA23250/004/002
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 15 mg film-coated tablets
PA23250/004/003
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 2.5 mg film-coated tablets
PA23250/004/001
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban MSN 20 mg film-coated tablets
PA23250/004/004
Rivaroxaban MSN Labs Europe Limited Not marketed
Rivaroxaban Pinewood 10 mg film coated tablets
PA0281/266/001
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Pinewood 15 mg film-coated tablets
PA0281/266/002
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Pinewood 20 mg film-coated tablets
PA0281/266/003
Rivaroxaban Pinewood Laboratories Limited Not marketed
Rivaroxaban Rowa 10 mg film-coated tablets
PA0074/097/001
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 15 mg film-coated tablets
PA0074/097/002
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowa 20 mg film-coated tablets
PA0074/097/003
Rivaroxaban Rowa Pharmaceuticals Limited, Not marketed
Rivaroxaban Rowex 10 mg film-coated tablets
PA0711/275/001
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Rowex 15 mg film-coated tablets
PA0711/275/002
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Rowex 20 mg film-coated tablets
PA0711/275/003
Rivaroxaban Rowex Limited, Marketed
Rivaroxaban Teva 10 mg film-coated tablets
PA22579/002/001
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 15 mg film-coated tablets
PA22579/002/002
Rivaroxaban TEVA GmbH Marketed
Rivaroxaban Teva 20 mg film-coated tablets
PA22579/002/003
Rivaroxaban TEVA GmbH Marketed
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.